Amgen and Kite Pharma in cancer immunotherapy pact
January 05, 2015 at 10:00 AM EST
Agreement to focus on Amgen’s cancer targets and Kite’s autologous cell therapy platform.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.